Telix Pharmaceuticals (TLPPF) Short Interest Ratio & Short Volume $15.01 -1.74 (-10.39%) As of 06/23/2025 03:19 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock Telix Pharmaceuticals Short Interest DataTelix Pharmaceuticals (TLPPF) has a short interest of 2.68 million shares. This marks a 0.39% increase in short interest from the previous month. The short interest ratio (days to cover) is 454.9, indicating that it would take 454.9 days of the average trading volume of 5,772 shares to cover all short positions.Current Short Interest2,684,000 sharesPrevious Short Interest2,673,700 sharesChange Vs. Previous Month+0.39%Dollar Volume Sold Short$43.02 millionShort Interest Ratio454.9 Days to CoverLast Record DateMay 31, 2025Today's Trading Volume3,700 sharesAverage Trading Volume5,772 sharesToday's Volume Vs. Average64% Short Selling Telix Pharmaceuticals? Sign up to receive the latest short interest report for Telix Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTLPPF Short Interest Over TimeTLPPF Days to Cover Over TimeTLPPF Percentage of Float Shorted Over Time Telix Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20252,684,000 shares $43.02 million +0.4%N/A454.9 $16.03 5/15/20252,673,700 shares $44.78 million +7.8%N/A116.2 $16.75 4/30/20252,479,300 shares $42.45 million +4.9%N/A227.5 $17.12 4/15/20252,363,600 shares $39.35 million +8.7%N/A513.8 $16.65 3/31/20252,174,100 shares $37.50 million +41.1%N/A194.1 $17.25 3/15/20251,541,200 shares $27.59 million +11.3%N/A223.4 $17.90 2/28/20251,384,700 shares $25.00 million +33.5%N/A123.6 $18.06 2/15/20251,037,100 shares $17.75 million +6.6%N/A125 $17.11 1/31/2025973,100 shares $17.51 million +5.3%N/A98.3 $17.99 1/15/2025923,800 shares $14.34 million -6.2%N/A151.4 $15.52 Get the Latest News and Ratings for TLPPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024984,600 shares $14.74 million +2.0%N/A273.5 $14.98 12/15/2024965,800 shares $15.45 million -4.1%N/A123.8 $16.00 11/30/20241,007,000 shares $15.61 million -9.8%N/A125.9 $15.50 11/15/20241,116,100 shares $16.74 million +10.7%N/A155 $15.00 10/31/20241,008,100 shares $13.45 million -15.5%N/A186.7 $13.34 10/15/20241,193,100 shares $17.27 million -4.8%N/A213.1 $14.48 9/30/20241,253,600 shares $18.40 million -3.2%N/A101.9 $14.68 9/15/20241,295,000 shares $16.51 million -3.5%N/A168.2 $12.75 8/31/20241,341,500 shares $18.11 million +47.1%N/A145.8 $13.50 8/15/2024912,200 shares $11.27 million +17.4%N/A86.1 $12.35 7/31/2024777,300 shares $9.56 million -64.0%N/A30 $12.30 7/15/20242,156,100 shares $29.54 million +2.7%N/A79.3 $13.70 6/30/20242,100,100 shares $26.57 million -6.1%N/A50.1 $12.65 6/15/20242,235,900 shares $24.39 million +59.8%N/A96 $10.91 5/31/20241,399,600 shares $17.10 million -0.2%N/A91.5 $12.22 5/15/20241,401,700 shares $14.31 million -6.6%N/A152.4 $10.21 4/30/20241,501,300 shares $14.71 million +12.8%N/A114.6 $9.80 4/15/20241,330,700 shares $11.55 million +4.8%N/A187.4 $8.68 3/31/20241,270,300 shares $10.73 million -5.4%N/A105.9 $8.45 3/15/20241,343,200 shares $10.38 million -1.3%N/A319.8 $7.73 2/29/20241,360,300 shares $11.20 million +2.9%N/A42.6 $8.23 2/15/20241,321,400 shares $10.03 million -27.0%N/A236 $7.59 1/15/20242,000,500 shares $14.00 million -1.5%N/A384.7 $7.00 12/31/20232,031,100 shares $13.96 million +4.6%N/A209.2 $6.88 12/15/20231,942,400 shares $12.59 million +3.5%N/A194.2 $6.48 11/30/20231,876,000 shares $12.25 million +35.2%N/A1103.5 $6.53 11/15/20231,387,200 shares $8.66 million +119.4%N/A182.5 $6.24 10/31/2023632,300 shares $3.60 million +16.6%N/A71 $5.70 10/15/2023542,100 shares $3.85 million -2.5%N/A115.3 $7.11 9/30/2023555,700 shares $4.11 million +2.4%N/A104.8 $7.39Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.We recently interviewed Rickards to get the full story and understand how everyday Americans can pre 9/15/2023542,800 shares $3.99 million +1.4%N/A113.1 $7.35 8/31/2023535,300 shares $3.88 million +57.3%N/A94.7 $7.26 8/15/2023340,400 shares $2.29 million +203.4%N/A68.1 $6.74 7/31/2023112,200 shares $835.89 thousand -20.3%N/A15.6 $7.45 7/15/2023140,800 shares $0.00 +3.2%N/A27.1 $0.00 TLPPF Short Interest - Frequently Asked Questions What is Telix Pharmaceuticals' current short interest? Short interest is the volume of Telix Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 2,684,000 shares of TLPPF short. Learn More on Telix Pharmaceuticals' current short interest. What is a good short interest ratio for Telix Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLPPF shares currently have a short interest ratio of 455.0. Learn More on Telix Pharmaceuticals's short interest ratio. Is Telix Pharmaceuticals' short interest increasing or decreasing? Telix Pharmaceuticals saw a increase in short interest in May. As of May 31st, there was short interest totaling 2,684,000 shares, an increase of 0.4% from the previous total of 2,673,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Telix Pharmaceuticals stock? Short selling TLPPF is an investing strategy that aims to generate trading profit from Telix Pharmaceuticals as its price is falling. TLPPF shares are trading down $1.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Telix Pharmaceuticals? A short squeeze for Telix Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLPPF, which in turn drives the price of the stock up even further. How often is Telix Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLPPF, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest AGNPF Short Interest AKBLF Short Interest APLMW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest AXIM Short Interest BCTXW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:TLPPF) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored"I'm risking my reputation on this"Crypto book predicted the last bull run (get it FREE now) This newly updated edition contains everything we...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.